Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Wright

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|January 1, 1996
Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care CenterM L Clements, M K Makhene, R A Karron, et al.
Vaccine|July 27, 1999
Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infantsM L Clements-Mann, M K Makhene, J Mrukowicz, et al.
The New England Journal of Medicine|December 19, 1991
Strategies for the global eradication of poliomyelitis by the year 2000P F Wright, R J Kim-Farley, C A de Quadros, et al.
The Journal of Infectious Diseases|December 1, 1977
Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccinesK M Boyer, J D Cherry, P F Wright, et al.
The Journal of Infectious Diseases|October 1, 1996
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adultsD L Lakey, J J Treanor, R F Betts, et al.
Journal of Biological Standardization|January 1, 1977
Endotoxin content and clinical reactivity to influenza vaccinesF A Ennis, W R Dowdle, D W Barry, et al.
The Journal of Infectious Diseases|December 1, 1985
Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virusS Feldman, P F Wright, R G Webster, et al.
Developments in Biological Standardization|June 1, 1977
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccinationG R Noble, H S Kaye, R J O'Brien, et al.
The Journal of Infectious Diseases|June 1, 1996
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators GroupW C Gruber, R B Belshe, J C King, et al.
Diagnostic Microbiology and Infectious Disease|August 25, 1999
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and BY W Tang, P J Heimgartner, S J Tollefson, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|January 1, 1996
Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care CenterM L Clements, M K Makhene, R A Karron, et al.
Vaccine|July 27, 1999
Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infantsM L Clements-Mann, M K Makhene, J Mrukowicz, et al.
The New England Journal of Medicine|December 19, 1991
Strategies for the global eradication of poliomyelitis by the year 2000P F Wright, R J Kim-Farley, C A de Quadros, et al.
The Journal of Infectious Diseases|December 1, 1977
Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccinesK M Boyer, J D Cherry, P F Wright, et al.
The Journal of Infectious Diseases|October 1, 1996
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adultsD L Lakey, J J Treanor, R F Betts, et al.
Journal of Biological Standardization|January 1, 1977
Endotoxin content and clinical reactivity to influenza vaccinesF A Ennis, W R Dowdle, D W Barry, et al.
The Journal of Infectious Diseases|December 1, 1985
Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virusS Feldman, P F Wright, R G Webster, et al.
Developments in Biological Standardization|June 1, 1977
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccinationG R Noble, H S Kaye, R J O'Brien, et al.
The Journal of Infectious Diseases|June 1, 1996
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators GroupW C Gruber, R B Belshe, J C King, et al.
Diagnostic Microbiology and Infectious Disease|August 25, 1999
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and BY W Tang, P J Heimgartner, S J Tollefson, et al.
Pageof 20